熱門資訊> 正文
Bioventus第三季度节拍激增
2025-11-05 01:36
- Bioventus (BVS) is up ~19% in Tuesday trading after posting Q3 financial results that beat on both lines.
- While net sales change year-over-year was essentially flat due to a ~29% decline in its restorative therapies segment, the medical device company saw strong growth of, respectively, 6.4% and 9.3%, in its two largest businesses, pain treatments and surgical solutions, to ~$67.2M and ~$50.2M.
- Pain treatment growth was driven by U.S. demand for Durolane, a hyaluronic acid therapy for knee osteoarthritis, while surgical solutions benefitted from US demand for bone graft substitutes and ultrasonics.
- The quarter's non-GAAP EPS of $0.15 compares to $0.05 in the year-ago period.
- Bioventus ended the quarter (Sept. 27) with cash and cash equivalents of $42.2M compared to ~$41.6M on Dec. 31, 2024.
More on Bioventus
- Bioventus Inc. (BVS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- Bioventus Inc. 2025 Q2 - Results - Earnings Call Presentation
- Bioventus Inc. (BVS) Q2 2025 Earnings Call Transcript
- Bioventus Non-GAAP EPS of $0.15 beats by $0.03, revenue of $138.7M beats by $0.51M
- Bioventus outlines path to $100M+ PNS revenue opportunity as new products receive clearance
推薦文章
美股機會日報 | 貴金屬史詩級牛市！黃金年內飆升70%，漲破4500美元關口；英特爾遭利空一度跌逾5%
聖誕節休市提醒：港股休市兩天半，美股休市一天半
谷歌年初在人工智能競賽中落后，卻在2025年末登頂行業榜首
華盛早報 | 美聯儲主席熱門人選哈塞特：降息節奏仍需加速！英偉達稱春節前向中國交付H200芯片；中芯國際對部分產能漲價10%
12月24日外盤頭條：美國消費者信心連續第五個月下滑 金銀連續兩日刷新歷史新高 特朗普提美聯儲主席必要條件
美聯儲主席候選人哈塞特：美國在降息方面已嚴重滯后
美股機會日報 | 黃金再創新高！現貨黃金逼近4500美元關口；甲骨文CEO埃里森為派拉蒙提供鉅額資金擔保
資金覆盤 | 北水淨買入港股6.11億港元，加倉阿里超13億港元，賣出騰訊超10億港元
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
